Form 8-K - Current report:
SEC Accession No. 0001193125-23-164490
Filing Date
2023-06-09
Accepted
2023-06-09 16:31:01
Documents
12
Period of Report
2023-06-06
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K d483697d8k.htm   iXBRL 8-K 29339
  Complete submission text file 0001193125-23-164490.txt   154388

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA icvx-20230606.xsd EX-101.SCH 2841
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE icvx-20230606_lab.xml EX-101.LAB 18737
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE icvx-20230606_pre.xml EX-101.PRE 11701
6 EXTRACTED XBRL INSTANCE DOCUMENT d483697d8k_htm.xml XML 3458
Mailing Address 1930 BOREN AVE., SUITE 1000 SEATTLE WA 98101
Business Address 1930 BOREN AVE., SUITE 1000 SEATTLE WA 98101 (206) 737-0085
Icosavax, Inc. (Filer) CIK: 0001786255 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40655 | Film No.: 231005813
SIC: 2836 Biological Products, (No Diagnostic Substances)